Tianjin Historical Income Statement
600488 Stock | 4.60 0.04 0.88% |
Historical analysis of Tianjin Tianyao income statement accounts such as Selling General Administrative of 1.2 B, Total Revenue of 4 B or Operating Income of 157.1 M can show how well Tianjin Tianyao Pharmaceuticals performed in making a profits. Evaluating Tianjin Tianyao income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Tianjin Tianyao's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Tianjin Tianyao Phar latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Tianjin Tianyao Phar is a good buy for the upcoming year.
Tianjin |
About Tianjin Income Statement Analysis
Tianjin Tianyao Phar Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Tianjin Tianyao shareholders. The income statement also shows Tianjin investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Tianjin Tianyao Income Statement Chart
Add Fundamental
Operating Income
Operating Income is the amount of profit realized from Tianjin Tianyao Phar operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Tianjin Tianyao Pharmaceuticals is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Cost Of Revenue
Cost of Revenue is found on Tianjin Tianyao Phar income statement and represents the costs associated with goods and services Tianjin Tianyao provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Tianjin Tianyao's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Tianjin Tianyao Phar current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Tianjin Tianyao Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Tianjin Tianyao's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 1.2 B, whereas Operating Income is forecasted to decline to about 157.1 M.
2021 | 2022 | 2023 | 2024 (projected) | Operating Income | 239.2M | 246.9M | 244.3M | 157.1M | Total Revenue | 3.7B | 3.7B | 3.8B | 4.0B |
Tianjin Tianyao income statement Correlations
Click cells to compare fundamentals
Tianjin Tianyao Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Tianjin Tianyao income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 36.7M | 40.2M | 45.9M | 48.2M | 36.7M | 38.5M | |
Selling General Administrative | 765.7M | 919.9M | 1.2B | 1.2B | 1.1B | 1.2B | |
Total Revenue | 2.9B | 3.1B | 3.7B | 3.7B | 3.8B | 4.0B | |
Operating Income | 306.7M | 223.1M | 239.2M | 246.9M | 244.3M | 157.1M | |
Cost Of Revenue | 1.5B | 1.7B | 2.0B | 1.9B | 2.0B | 1.1B | |
Income Before Tax | 253.0M | 112.4M | 149.1M | 12.5M | 168.2M | 117.9M | |
Net Income Applicable To Common Shares | 145.2M | 161.8M | 34.0M | 35.4M | 40.7M | 38.7M | |
Net Income | 145.3M | 34.0M | 48.7M | 35.4M | 117.1M | 87.9M | |
Income Tax Expense | 76.3M | 31.8M | 40.4M | (5.9M) | (6.8M) | (6.5M) | |
Minority Interest | 755.6M | 781.1M | (60.0M) | 17.0M | (45.6M) | (43.3M) | |
Research Development | 129.4M | 138.1M | 133.3M | 142.7M | 161.1M | 117.7M | |
Gross Profit | 1.4B | 1.4B | 1.8B | 1.8B | 1.8B | 1.3B | |
Other Operating Expenses | 32.6M | 31.5M | 18.8M | 40.2M | 46.2M | 29.2M | |
Net Income From Continuing Ops | 183.2M | 80.6M | 108.7M | 18.4M | 162.7M | 93.8M | |
Ebit | 322.8M | 178.0M | 178.2M | 181.3M | 208.4M | 210.5M | |
Total Operating Expenses | 2.6B | 2.9B | 3.5B | 3.4B | 3.5B | 2.7B | |
Tax Provision | 69.8M | 31.8M | 40.4M | (5.9M) | 5.6M | 5.3M | |
Net Interest Income | (37.2M) | (41.1M) | (46.6M) | (45.5M) | (29.0M) | (30.5M) | |
Interest Income | 2.3M | 2.3M | 2.1M | 4.4M | 8.6M | 5.2M | |
Ebitda | 432.5M | 336.3M | 403.7M | 317.8M | 365.4M | 394.4M | |
Reconciled Depreciation | 142.8M | 183.7M | 208.8M | 257.1M | 271.1M | 199.9M |
Currently Active Assets on Macroaxis
Other Information on Investing in Tianjin Stock
Tianjin Tianyao Phar Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Tianjin Tianyao shareholders. The income statement also shows Tianjin investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).